HBHyo-Jin Byon

Hyo-Jin Byon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hyo-Jin Byon has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Jin-Tae Kim

    Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

    2 shared publications
  • C. Kim

    1 shared publication
  • Chan Ho Jeong

    Department of Anesthesiology and Pain Medicine, Inha University School of Medicine, Incheon, Korea

    1 shared publication
  • C‐H. Jeong

    Department of Anesthesiology and Pain Medicine Inha University Hospital Incheon Korea

    1 shared publication
  • H. K. Shin

    Department of Anesthesiology and Pain Medicine Inha University Hospital Incheon Korea

    1 shared publication
  • H. Kim

    Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

    1 shared publication

Latest Publications

  • Open Access

    A Novel Propofol Dosing Regimen for Pediatric Sedation during Radiologic Tests

    by Ji-Young Min, Jeong-Rim Lee, Hye-Mi Lee, Ho-Jae Nam, Hyo-Jin Byon

    The dose of propofol for pediatric sedation during radiologic tests has been proposed as an equation of 0.75 + 0.14 × age (months) + 45.82 × body surface area (m2) based on results in a previous study. We compared this equation and the conventional dosing strategy for sedation in children undergoing radiologic tests. An amount of 180 children scheduled for magnetic resonance imaging (MRI) were randomized to experimental and control groups. The initial induction dose of propofol calculated using the equation was administered in the experimental group. In the control group, children received 1 mg/kg of the initial induction dose of propofol. Then, 0.5 mg/kg of the additional dose was followed to induce sedation in both groups. When awake or moving, a rescue injection of 0.5 mg/kg propofol was given. The total induction dose was more significant in the experimental group. The number of injections for induction in the experimental group was lesser. The dose and number of rescue injections in the experimental group were significantly less. The equation for the induction dose of propofol in a previous study could achieve quick induction of sedation and prevent a rescue injection during sedation. However, caution is needed when using the equation.


  • Open Access

    Appropriate dose of dexmedetomidine for the prevention of emergence agitation after desflurane anesthesia for tonsillectomy or adenoidectomy in children: up and down sequential allocation

    by Hee-Soo Kim, Hyo-Jin Byon, Jong-Eun Kim, Yong-Hee Park, Ji-Hyun Lee, Jin-Tae Kim

    Dexmedetomidine can be used for the prevention of emergence agitation (EA) in children. However, an inadequate dose of dexmedetomidine can induce prolonged sedation and cardiovascular complications. The aim of this study was to evaluate the effective dose of dexmedetomidine for the prevention of EA after desflurane anesthesia for patients undergoing a tonsillectomy or adenoidectomy. We enrolled 21 unpremedicated children, between 2 and 12 years, undergoing either a tonsillectomy or an adenoidectomy. General anesthesia was induced using sevoflurane and oxygen, and dexmedetomidine was administered before surgery. Anesthesia was maintained using desflurane resulting in a BIS range of 40–60. In the postanesthetic care unit (PACU), EA (agitation measured at level 4 or more at least once) was assessed on arrival in the PACU,15 min later, and 30 min later. The dose of dexmedetomidine for consecutive patients was determined by the response of the previous patient, using an increment or decrement of 0.1 μg/kg. The 50 % effective dose of dexmedetomidine for prevention of EA was 0.25 μg/kg (95 % confidence limits, 0.17–0.33 μg/kg), and the 95 % effective dose was 0.38 μg/kg (95 % confidence limits, 0.29–0.39 μg/kg). For prevention of EA after desflurane anesthesia for 50 % and 95 % of children undergoing tonsillectomies or adenoidectomies, 0.25 μg/kg or 0.38 μg/kg of dexmedetomidine is suggested. Further study is needed to validate the suggested dose of dexmedetomidine to prevent the EA that was identified in the present study. Clinical Research Information Service KCT0000126 .


  • Open Access

    Comparison between Glidescope and Lightwand for tracheal intubation in patients with a simulated difficult airway

    by Ki-Hwan Yang, Chan Ho Jeong, Kyung Chul Song, Jeong Yun Song, Jang-Ho Song, Hyo-Jin Byon

    Yang KH, et al. Korean J Anesthesiol. 2015 Feb;68(1):22-26. http://dx.doi.org/10.4097/kjae.2015.68.1.22


  • Open Access

    Predicting the optimal depth of left‐sided central venous catheters in children

    by H. Kim, C‐H. Jeong, H‐J. Byon, H. K. Shin, T. J. Yun, J‐H. Lee, Y‐H. Park, J‐T. Kim

    Summary: The aim of this study was to predict the optimal depth for insertion of a left‐sided central venous catheter in children. Using 3D chest computed tomography angiography, we measured the distance from a point where the internal jugular vein is at the superior border of the clavicle, and from a point where the subclavian vein is inferior to the anterior border of the clavicle, to the junction of the superior vena cava and the right atrium in 257 children. Linear regression analysis revealed that the distances correlated with age, weight and height. Simple formulae for the depth of a central venous catheter via the left internal jugular vein (0.07 × height (cm)) and the left subclavian vein (0.08 × height (cm)) were developed to predict placement of the central venous catheter tip at the junction of the superior vena cava with the right atrium. Using these fomulae, the proportion of catheter tips predicted to be correctly located was 98.5% (95% CI 96.8–100%) and 94.0% (95% CI 90.8–97.3%), respectively.


  • Potential Risk for Intra-Aortic Balloon-Induced Obstruction to the Celiac Axis or the Renal Artery in the Asian Population

    by H.-J. Byon, H.-C. Kim, J.-T. Kim, H.-S. Kim, S.-C. Lee, C. Kim

    To evaluate the potential risk for intra-aortic balloon (IAB)-induced obstruction to the celiac axis (CA) or the renal artery (RA) when IAB size is chosen according to patient height and the tip is placed 2 cm distal to the origin of the left subclavian artery (LSCA), the computed tomography images of 150 Asian adults were reviewed to identify the distance from the LSCA to the CA (LSCA‐CA) and to the RA (LSCA‐RA). The diameter of the aorta at the level of the T9 vertebra, CA, and RA was also measured. The length and caliber of the IAB was selected according to two manufacturer's recommendations (Datascope Corp and Tokai Medical Products). The Datascope IAB potentially blocked the CA in 84 % and the RA in 66 %, while the Tokai IAB obstructed the CA in 61 % and the RA in 10 % of cases. The caliber of the IAB overlying the orifice of the RA was longer than the diameter of the aorta in 5 cases (3.3 %) using the Datascope IAB, and in 1 case (0.7 %) using the Tokai IAB. When placing an IAB selected based on patient height, the IAB could obstruct the orifice of the CA and RA in the majority of Asian patients, especially a Datascope IAB.